Home  >  Good Clinical Practices
Msc_Apr23 Advertisement
you can get e-magazine links on WhatsApp. Click here
Good Clinical Practices
  GCP norms recommend sponsor should notify regulatory authority,   May 31, 2023
  EC review should focus on all potential ethical issues,   May 04, 2023
  Sponsor can analyse sample collected prior to withdrawal of consent,   April 05, 2023
  Sponsor can analyse sample collected prior to withdrawal of consent,   April 05, 2023
  Using 1 central EC for non-interventional study would be non-compliance,   March 01, 2023
  IEC member reviews study without prior knowledge of the study,   February 01, 2023
  Certified copy of original record is a copy that has been verified,   January 04, 2023
  Use of e-mail in place of correspondence is acceptable practice,   November 30, 2022
  EC should advise investigator against recruitment of family member,   November 02, 2022
  EC should review information contained in advertisements and mode of communication,   October 05, 2022
  Patients’ travel expenses need review and approval from Ethics Committee,   September 01, 2022
  Review of source data is critical to ensure quality of trial conduct,   August 03, 2022
  It is mandatory to notify CDSCO about protocol deviations,   June 01, 2022
  Non-interventional study for active surveillance needs CDSCO nod,   May 04, 2022
  It is not mandatory to provide results of clinical trial in CTRI,   April 06, 2022
  Investigator can archive records at a location outside institution,   March 01, 2022
  No specific norms describe family volunteering in a clinical trial,   February 01, 2022
  Usability studies assess ability of future participants for using DHT,   January 05, 2022
  Investigational product should be suitable for delivery to participant,   December 01, 2021
  Regulatory GCP inspections identify many gaps in clinical trial contracts,   November 03, 2021

 Back
 
PharmaLytica
CPhI_China_2023
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |